Nathan Trainin, M.D. - Publications

Affiliations: 
Cell Biology Weizmann Institute of Science, Rehovot, Israel 
Area:
Thymic Humoral Factor
Website:
https://www.weizmann.ac.il/immunology/about-us/in-memoriam

106 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1999 Ophir R, Moalem G, Pecht M, Shashoua M, Rashid G, Ben-Efraim S, Trainin N, Burstein Y, Keisari Y. THF-gamma 2-mediated reduction of pulmonary metastases and augmentation of immunocompetence in C57BL/6 mice bearing B16-melanoma. Journal of Immunotherapy (Hagerstown, Md. : 1997). 22: 103-13. PMID 10093035 DOI: 10.1097/00002371-199903000-00002  0.412
1997 Ophir G, Pecht M, Lourie S, Meshorer A, Ben-Efraim S, Trainin N, Burstein Y, Keisari Y. The therapeutic effect of intra-nasal administration of thymic humoral factor-γ2 (THF-γ2) combined with chemotherapy in mice bearing metastatic lung tumors Immunology Letters. 56: 338. DOI: 10.1016/S0165-2478(97)86370-5  0.389
1996 Ophir R, Pecht M, Keisari Y, Rashid G, Lourie S, Meshorer A, Ben-Efraim S, Trainin N, Burstein Y. Thymic humoral factor-gamma 2 (THF-gamma 2) immunotherapy reduces the metastatic load and restores immunocompetence in 3LL tumor-bearing mice receiving anticancer chemotherapy. Immunopharmacology and Immunotoxicology. 18: 209-36. PMID 8771368 DOI: 10.3109/08923979609052733  0.444
1996 Palmon A, Blagerman S, Tel-Or S, Pecht M, Trainin N, Burstein Y, Rager-Zisman B. Treatment of murine cytomegalovirus salivary-gland infection by combined therapy with ganciclovir and thymic humoral factor γ2 Antiviral Research. 33: 55-64. DOI: 10.1016/S0166-3542(96)00996-5  0.3
1993 Rager-Zisman B, Segev Y, Blagerman S, Palmon A, Tel-Or S, Pecht M, Trainin N, Burstein Y. Thymic humoral factor, THF-γ2, enhances immunotherapy of murine cytomegalovirus (MCMV) infection by both CD4+ and CD8+ immune T cells Immunology Letters. 39: 23-31. PMID 7908278 DOI: 10.1016/0165-2478(93)90160-4  0.402
1991 Pecht M, Netzer L, Levy A, Lourie S, David M, Zipori D, Barak Y, Burstein Y, Trainin N. Enhancement of myeloid progenitor cells growth in bone marrow of intact and neonatally thymectomized mice by synthetic thymic hormone, THF-γ2 International Journal of Immunopharmacology. 13: 797. DOI: 10.1016/0192-0561(91)90354-A  0.418
1990 Ophir R, Pecht M, Relyveld EH, Burstein Y, Ben-Efraim S, Trainin N. THF-gamma 2, a synthetic thymic hormone, increases effectiveness of combined chemotherapy and immunotherapy against RPC-5 murine plasmacytoma. International Journal of Immunopharmacology. 12: 751-4. PMID 2292455 DOI: 10.1016/0192-0561(90)90038-O  0.435
1990 Rager-Zisman B, Zuckerman F, Benharroch D, Pecht M, Burstein Y, Trainin N. Therapy of a fatal murine cytomegalovirus infection with thymic humoral factor (THF-gamma 2) treated immune spleen cells. Clinical and Experimental Immunology. 79: 246-52. PMID 2155728 DOI: 10.1111/J.1365-2249.1990.Tb05186.X  0.44
1989 Tamir M, Harris N, Trainin N, Toledo J, Zipori D. Multilineage hemopoiesis induced by cloned stromal cells. International Journal of Cell Cloning. 7: 373-84. PMID 2809273 DOI: 10.1002/Stem.5530070605  0.384
1989 Small M, Trainin N, Aronson M. Influence of a thymic hormone on cultured epithelial cells of the thymus. Thymus. 13: 227-35. PMID 2617578  0.677
1989 Ophir R, Pecht M, Halperin D, Rashid G, Burstein Y, Ben-Efraim S, Trainin N. THF-gamma 2, a thymic hormone, increases immunocompetence and survival in 5-fluorouracil-treated mice bearing MOPC-315 plasmacytoma. Cancer Immunology, Immunotherapy : Cii. 30: 119-25. PMID 2598178 DOI: 10.1007/Bf01665963  0.46
1987 Handzel ZT, Berner Y, Segal O, Burstein Y, Buchner V, Pecht M, Levin S, Burstein R, Milchan R, Bentwich Z, Ben-Ishai Z, Trainin N. Immunoreconstitution of T-cell impairments in asymptomatic male homosexuals by thymic humoral factor (THF). International Journal of Immunopharmacology. 9: 165-173. PMID 3294619 DOI: 10.1016/0192-0561(87)90091-9  0.345
1987 Bentwich Z, Saxinger C, Ben-Ishay Z, Burstein R, Berner Y, Pecht M, Trainin N, Levin S, Handzel ZT. Immune impairments and antibodies to HTLVIII/LAV in asymptomatic male homosexuals in Israel: relevance to the risk of acquired immune deficiency syndrome (AIDS). Journal of Clinical Immunology. 7: 376-80. PMID 2443528 DOI: 10.1007/Bf00917015  0.329
1986 Shohat B, Hirsch M, Jardena O, Henry J, Levy I, Trainin N. Cellular immune aspects of the human fetal-maternal relationship. American Journal of Reproductive Immunology and Microbiology : Ajrim. 11: 125-9. PMID 3490187 DOI: 10.1111/J.1600-0897.1986.Tb00045.X  0.326
1985 Mukamel E, Umiel T, Shohat B, Pecht M, Servadio C, Trainin N. A mouse ear reaction for assessment of human lymphocyte immunocompetence. Immunobiology. 169: 21-9. PMID 3886530 DOI: 10.1016/S0171-2985(85)80050-4  0.343
1985 Wysenbeek AJ, Trainin N, Cathcart M, Krakauer RS. The influence of thymic humoral factor on systemic lupus erythematosus lymphocyte function International Journal of Immunopharmacology. 7: 603-607. PMID 3876300 DOI: 10.1016/0192-0561(85)90083-9  0.326
1985 Shohat B, Ideses C, David M, Feuerman EJ, Trainin N. In vitro induction of T-suppressor lymphocytes by THF, a thymic hormone, in psoriatic children. Dermatology. 171: 226-232. PMID 2934278 DOI: 10.1159/000249427  0.338
1985 Andrews P, Shortman K, Scollay R, Potworowski EF, Kruisbeek AM, Goldstein G, Trainin N, Bach JF. Thymus hormones do not induce proliferative ability or cytolytic function in PNA+ cortical thymocytes. Cellular Immunology. 91: 455-66. PMID 2581700 DOI: 10.1016/0008-8749(85)90243-6  0.361
1984 Umiel T, Friedman E, Luria D, Cohen IJ, Kaplinsky H, Netzer L, Pecht M, Trainin N, Zaizov R. Impaired immune regulation in children and adolescents with hemophilia and thalassemia in Israel. Journal of Pediatric Hematology Oncology. 6: 371-378. PMID 6241995 DOI: 10.1097/00043426-198424000-00003  0.338
1983 Grinblat J, Schauenstein K, Saltz E, Trainin N, Globerson A. Regulatory effects of thymus humoral factor on T cell growth factor in aging mice. Mechanisms of Ageing and Development. 22: 209-18. PMID 6605463 DOI: 10.1016/0047-6374(83)90077-5  0.453
1982 Gozes Y, Umiel T, Trainin N. Selective decline in differentiating capacity of immunohemopoietic stem cells with aging Mechanisms of Ageing and Development. 18: 251-259. DOI: 10.1016/0047-6374(82)90114-2  0.452
1980 Gabizon A, Trainin N. Enhancement of growth of a radiation-induced lymphoma by T cells from normal mice British Journal of Cancer. 42: 551-558. DOI: 10.1038/bjc.1980.279  0.33
1979 Rotter V, Yakir Y, Trainin N. Role of L-alanine in the response of human lymphocytes to PHA and Con A Journal of Immunology. 123: 1726-1731. PMID 573302  0.448
1979 Zaizov R, Vogel R, Wolach B, Cohen IJ, Varsano I, Shohat B, Handzel Z, Rotter V, Yakir Y, Trainin N. The effect of THF in lymphoproliferative and myeloproliferative diseases in children. Annals of the New York Academy of Sciences. 332: 172-83. PMID 294830 DOI: 10.1111/J.1749-6632.1979.Tb47110.X  0.443
1979 Rotter V, Trainin N. Role of thymic hormone (THF) and of a thymic plasma recirculating factor (TPRF) in the modulation of human lymphocyte response to PHA and Con A Journal of Immunology. 122: 414-420. PMID 216747  0.466
1979 Handzel ZT, Dolfin Z, Levin S, Altman Y, Hahn T, Trainin N, Gadot N. Effect of thymic humoral factor on cellular immune factors of normal children and of pediatric patients with ataxia telangiectasia and Down's syndrome. Pediatric Research. 13: 803-6. PMID 158166 DOI: 10.1203/00006450-197907000-00002  0.319
1979 Trainin N, Rotter V, Yakir Y, Leve R, Handzel Z, Shohat B, Zaizov R. Biochemical and biological properties of THF in animal and human models Annals of the New York Academy of Sciences. 332: 9-22. PMID 43694 DOI: 10.1111/J.1749-6632.1979.Tb47093.X  0.455
1979 Shohat B, Wolach B, Trainin N. Effect of thymic humoral factor in vitro on human bone marrow and blood cells from B-, T- and null-cell acute lymphatic leukemia. Cellular Immunology. 45: 255-60. PMID 38011 DOI: 10.1016/0008-8749(79)90386-1  0.409
1979 Shohat B, Trainin N. Effect of thymic humoral factor (THF) in vitro on bone marrow and blood cells from B, T and null cell acute lymphatic leukemia (ALL). Advances in Experimental Medicine and Biology. 114: 599-603. PMID 37720 DOI: 10.1007/978-1-4615-9101-6_99  0.374
1979 Zaizov R, Vogel R, Wolach B, Shohat B, Handzel Z, Yakir V, Rotter V, Trainin N. 39 THE EFFECT OF THE IN IMMUNOSUPPRESSED CHILDREN WITH LYMPHO PROLIFERATIVE DISEASES Pediatric Research. 13: 954-954. DOI: 10.1203/00006450-197908000-00055  0.49
1979 Trainin N, Yakir Y, Kook AI. CORRELATION BETWEEN THE CELLULAR LEVELS OF cAMP, CELL-MEDIATED IMMUNOCOMPETENCE AND THE THYMIC HUMORAL FACTOR (THF) Cell Biology and Immunology of Leukocyte Function. 201-211. DOI: 10.1016/B978-0-12-569650-0.50030-9  0.433
1978 Umiel T, Linker-Israeli M, Itzchaki M, Trainin N, Reisner Y, Sharon N. Inhibition or acceleration of tumor growth by subpopulations of thymus cells separable by a peanut lectin. Cellular Immunology. 37: 134-41. PMID 306880 DOI: 10.1016/0008-8749(78)90181-8  0.411
1978 Trainin N, Small M. T-lymphocytes and modulation of tumor growth. Comprehensive Therapy. 4: 31-4. PMID 304794  0.662
1978 Rotter V, Fink A, Trainin N. In vitro allogeneic response of human lymphocytes dependent upon dialyzable plasma components and a thymic hormone, THF Cellular Immunology. 36: 242-250. PMID 147137 DOI: 10.1016/0008-8749(78)90268-X  0.514
1978 Yakir Y, Kook AI, Trainin N. Enrichment of in vitro and in vivo immunologic activity of purified fractions of calf thymic hormone. The Journal of Experimental Medicine. 148: 71-83. PMID 27568 DOI: 10.1084/Jem.148.1.71  0.387
1978 Handsel ZT, Levin S, Shneyour A, Trainin N, Beer S, Vure E. THE POTENTIAL OF THYMUS HUMORAL FACTOR (THE) TREATMENT OF IMMUNODEFICIENT PATIENTS Pediatric Research. 12: 67-67. DOI: 10.1203/00006450-197801000-00042  0.354
1977 Gozes Y, Trainin N. Enhancement of Lewis lung carcinoma in a syngeneic host by spleen cells of C57BL/6 old mice. European Journal of Immunology. 7: 159-64. PMID 862655 DOI: 10.1002/Eji.1830070309  0.48
1977 Rotter V, Trainin N. Effect of thymic hormone on the response of different lymphoid cell populations to T mitogens Israel Journal of Medical Sciences. 13: 363-370. PMID 301520  0.578
1977 Zaizov R, Vogel R, Cohen I, Varsano I, Shohat B, Rotter V, Trainin N. Thymic hormone (THF) therapy in immunosuppressed children with lymphoproliferative neoplasia and generalized varicella Biomedicine Express. 27: 105-108. PMID 268220  0.463
1977 Varsano I, Schonfeld TM, Matoth Y, Shohat B, Englander T, Rotter V, Trainin N. Severe disseminated adenovirus infection successfully treated with a thymic humoral factor, THF. Acta Paediatrica Scandinavica. 66: 329-31. PMID 194457 DOI: 10.1111/J.1651-2227.1977.Tb07902.X  0.513
1977 Umiel T, Trainin N. Increased reactivity of responding cells in the mixed lymphocyte reaction by a thymic humoral factor. European Journal of Immunology. 5: 85-8. PMID 135681 DOI: 10.1002/Eji.1830050203  0.488
1977 Umiel T, Globerson A, Trainin N. Development of immunosuppressor cells. Exertion of specific suppression by neonatal liver cells. Transplantation. 24: 282-9. PMID 21476 DOI: 10.1097/00007890-197710000-00008  0.341
1976 Umiel T, Trainin N. The role of the thymus in the establishment of suppressor cells in liver chimeras. Cellular Immunology. 23: 232-9. PMID 1277304 DOI: 10.1016/0008-8749(76)90189-1  0.381
1976 Umiel T, Altman A, Trainin N. Augmentation of Cell Mediated Lysis (CML) by THF Advances in Experimental Medicine and Biology. 66: 639-643. PMID 1083661 DOI: 10.1007/978-1-4613-4355-4_98  0.384
1976 Rotter V, Trainin N. Depletion of suppressor T cells in syngeneic chimeric mice Advances in Experimental Medicine and Biology. 66: 593-598. PMID 1083656 DOI: 10.1007/978-1-4613-4355-4_92  0.623
1976 Rotter V, Schlesinger M, Kalderon R, Trainin N. Response of human lymphocytes to PHA and Con A, dependent on and regulated by THF, a thymic hormone Journal of Immunology. 117: 1927-1932. PMID 993589  0.472
1976 Gabizon A, Small M, Trainin N. Kinetics of the response of spleen cells from tumor-bearing animals in an in vivo tumor neutralization assay. International Journal of Cancer. 18: 813-9. PMID 992909 DOI: 10.1002/Ijc.2910180613  0.732
1976 Small M, Trainin N. Separation of populations of sensitized lymphoid cells into fractions inhibiting and fractions enhancing syngeneic tumor growth in vivo. Journal of Immunology (Baltimore, Md. : 1950). 117: 292-7. PMID 932428  0.703
1976 Small M, Trainin N. Control of autoimmune processes by a thymic humoral factor (THF). Advances in Experimental Medicine and Biology. 66: 659-64. PMID 4966 DOI: 10.1007/978-1-4613-4355-4_102  0.677
1975 Umiel T, Trainin N. Immunological enhancement of tumor growth by syngeneic thymus-derived lymphocytes. Transplantation. 18: 244-50. PMID 4608685 DOI: 10.1097/00007890-197409000-00007  0.399
1975 Small M, Trainin N. Proceedings: Control of autoreactivity by a humoral factor of the thymus. Israel Journal of Medical Sciences. 11: 1382-3. PMID 1218982  0.646
1975 Small M, Trainin N. Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitized on tumor-cell monolayers in the presence of the thymic humoral factor. International Journal of Cancer. 15: 962-72. PMID 1150350 DOI: 10.1002/Ijc.2910150612  0.734
1975 Rotter V, Trainin N. Inhibition of tumor growth in syngeneic chimeric mice mediated by a depletion of suppressor T cells Transplantation. 20: 68-74. PMID 1101476 DOI: 10.1097/00007890-197507000-00011  0.645
1975 Rotter V, Trainin N. Increased mitogenic reactivity of normal spleen cells to T lectins induced by thymus humoral factor (THF) Cellular Immunology. 16: 413-421. PMID 1090382 DOI: 10.1016/0008-8749(75)90130-6  0.599
1975 Rotter V, Trainin N. Proceedings: Increased mitogenic reactivity of lymphoid cells to T lectins induced by thymus humoral factor Israel Journal of Medical Sciences. 11: 1381-1382. PMID 1082875  0.527
1975 Rotter V, Trainin N. Elimination of suppressor T-cells in mice undergoing a graft-versus-host reaction expressed by increased response to polyvinylpyrrolidone (PVP) Cellular Immunology. 18: 199-209. PMID 237632 DOI: 10.1016/0008-8749(75)90048-9  0.629
1975 Small M, Trainin N. Control of autoreactivity by a humoral factor of the thymus (THF). Cellular Immunology. 20: 1-11. PMID 1151 DOI: 10.1016/0008-8749(75)90078-7  0.76
1974 Rotter V, Trainin N. Thymus cell population exerting a regulatory function in the immune response of mice to polyvinyl pyrrolidone Cellular Immunology. 13: 76-86. PMID 4615810 DOI: 10.1016/0008-8749(74)90228-7  0.62
1974 Carnaud C, Ilfeld D, Levo Y, Trainin N. EnhancemenT of 3LL tumor growth by autosensitized t lymphocytes independent of the host lymphatic system. International Journal of Cancer. 14: 168-175. PMID 4549211 DOI: 10.1002/Ijc.2910140205  0.412
1974 Treves AJ, Carnaud C, Trainin N, Feldman M, Cohen IR. Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor. European Journal of Immunology. 4: 722-7. PMID 4547711 DOI: 10.1002/Eji.1830041104  0.457
1974 Carnaud C, Ilfeld D, Brook I, Trainin N. Increased reactivity of mouse spleen cells sensitized in vitro against syngeneic tumor cells in the presence of a thymic humoral factor. The Journal of Experimental Medicine. 138: 1521-32. PMID 4543457 DOI: 10.1084/Jem.138.6.1521  0.439
1974 Trainin N, Levo Y, Rotter V. Resistance to hydrocortisone conferred upon thymocytes by a thymic humoral factor European Journal of Immunology. 4: 634-637. PMID 4154201 DOI: 10.1002/Eji.1830040913  0.546
1974 Nemirovsky T, Trainin N. Leukemia induction in C3H mice following their inoculation with normal AKR lymphoid cells. International Journal of Cancer. 11: 172-7. PMID 4151449 DOI: 10.1002/Ijc.2910110120  0.433
1974 Ilfeld D, Carnaud C, Cohen IR, Trainin N. In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro. International Journal of Cancer. 12: 213-22. PMID 4133584 DOI: 10.1002/Ijc.2910120122  0.437
1974 Carnaud C, Hoch B, Trainin N. Influence of Immunologic Competence of the Host on Metastases Induced by the 3LL Lewis Tumor in Mice2 Jnci: Journal of the National Cancer Institute. 52: 395-399. DOI: 10.1093/Jnci/52.2.395  0.405
1974 Kook AI, Trainin N. HORMONE-LIKE ACTIVITY OF A THYMUS HUMORAL FACTOR ON THE INDUCTION OF IMMUNE COMPETENCE IN LYMPHOID CELLS Journal of Experimental Medicine. 139: 193-207. DOI: 10.1084/Jem.139.1.193  0.46
1974 Levo Y, Carnaud C, Cohen IR, Trainin N. Increased Incidence of Urethane Induced Lung Adenomata by Autosensitized Lymphocytes British Journal of Cancer. 29: 312-317. DOI: 10.1038/Bjc.1974.72  0.457
1974 Carnaud C, Markowicz O, Trainin N. The influence of a graft-versus-host reaction on the incidence of metastases after tumor transplantation Cellular Immunology. 14: 87-97. DOI: 10.1016/0008-8749(74)90172-5  0.385
1973 Globerson A, Rotter V, Nakamura I, Trainin N. Thymus extracts induce differentiation of thymus derived cells. Advances in Experimental Medicine and Biology. 29: 183-9. PMID 4605385 DOI: 10.1007/978-1-4615-9017-0_27  0.598
1973 Rotter V, Globerson A, Nakamura I, Trainin N. Studies on characterization of the lymphoid target cell for activity of a thymus humoral factor. The Journal of Experimental Medicine. 138: 130-42. PMID 4577615 DOI: 10.1084/Jem.138.1.130  0.623
1973 Lonai P, Mogilner B, Rotter V, Trainin N. Studies on the effect of a thymic humoral factor on differentiation of thymus derived lymphocytes European Journal of Immunology. 3: 21-26. PMID 4146225 DOI: 10.1002/Eji.1830030106  0.63
1973 Zipori D, Trainin N. Defective Capacity of Bone Marrow From Nude Mice to Restore Lethally Irradiated Recipients Blood. 42: 671-678. DOI: 10.1182/Blood.V42.5.671.671  0.441
1973 TRAININ N, CARNAUD C, ILFELD D. Inhibition of in vitro Autosensitization by a Thymic Humoral Factor Nature New Biology. 245: 253-255. DOI: 10.1038/Newbio245253A0  0.403
1971 Small M, Trainin N. Contribution of a thymic humoral factor to the development of an immunologically competent population from cells of mouse bone marrow. The Journal of Experimental Medicine. 134: 786-800. PMID 15776575 DOI: 10.1084/Jem.134.3.786  0.733
1971 Sontag JM, Berenblum I, Trainin N. A cytological study of bone marrow and peripheral blood of irradiated and nonirradiated mice treated with 19S alpha-2 globulin (alpha-2-MG). Radiation Research. 45: 511-21. PMID 4102389 DOI: 10.2307/3573060  0.564
1971 Sontag JM, Trainin N, Berenblum I. A quantitative analysis of bone marrow cell populations in irradiated and nonirradiated mice treated with 19S alpha-2 globulin (alpha-2-MG). Radiation Research. 45: 499-510. PMID 4102388  0.58
1971 RESNITZKY P, ZIPORI D, TRAININ N. Effect of Neonatal Thymectomy on Hemopoietic Tissue in Mice Blood. 37: 634-646. DOI: 10.1182/Blood.V37.6.634.634  0.438
1970 Trainin N, Small M. Conferment of immunocompetence on lymphoid cells by a thymic humoral factor. Ciba Foundation Study Group. 36: 24-41. PMID 4399434  0.7
1970 Trainin N, Small M. Studies on some physicochemical properties of a thymus humoral factor conferring immunocompetence on lymphoid cells. The Journal of Experimental Medicine. 132: 885-97. PMID 4394277 DOI: 10.1084/Jem.132.5.885  0.751
1969 Trainin N, Small M, Globerson A. Immunocompetence of spleen cells from neonatally thymectomized mice conferred in vitro by a syngeneic thymus extract. The Journal of Experimental Medicine. 130: 765-75. PMID 4390489 DOI: 10.1084/Jem.130.4.765  0.754
1969 Linker-Israeli M, Trainin N. Influence of adult thymectomy on growth of transplanted tumors in mice Transplantation. 7: 151-152. DOI: 10.1093/Jnci/41.2.411  0.366
1969 TRAININ N, RESNITZKY P. Influence of Neonatal Thymectomy on Cloning Capacity of Bone Marrow Cells in Mice Nature. 221: 1154-1155. DOI: 10.1038/2211154A0  0.358
1968 Berenblum I, Chen L, Trainin N. A quantitative study of the leukemogenic action of whole-body x-irradiation and urethane. I. In adult C57BL mice. Israel Journal of Medical Sciences. 4: 1159-63. PMID 5756642  0.589
1967 Berenblum I, Trainin N, Cividalli G, Boiato-Chen L, Knyszynski A. Conditions affecting the inhibitory action of RLP on radiation leukaemogenesis in mice. Tumori. 53: 5-17. PMID 6059117  0.595
1967 Trainin N, Linker-Israeli M, Small M, Boiato-Chen L. Enhancement of lung adenoma formation by neonatal thymectomy in mice treated with 7,12-dimethylbenz(a)anthracene or urethan. International Journal of Cancer. 2: 326-36. PMID 6055972 DOI: 10.1002/Ijc.2910020407  0.731
1967 Small M, Trainin N. Increase in antibody-forming cells ofneonatally thymectomized mice receiving calf thymus extract. Nature. 216: 377-9. PMID 6053817 DOI: 10.1038/216377A0  0.758
1967 Trainin N, Burger M, Kaye AM. Some characteristics of a thymic humoral factor determined by assay in vivo of DNA synthesis in lymph nodes of thymectomized mice Biochemical Pharmacology. 16: 711-720. PMID 6033790 DOI: 10.1016/0006-2952(67)90084-6  0.332
1966 Trainin N, Bejerano A, Strahilevitch M, Goldring D, Small M. A thymic factor preventing wasting and influencing lymphopoiesis in mice. Israel Journal of Medical Sciences. 2: 549-59. PMID 5970641  0.706
1966 Berenblum I, Boiato L, Trainin N. On the mechanism of urethan leukemogenesis in newborn C57BL mice. I. Influence of injections of syngeneic bone marrow cell suspensions. Cancer Research. 26: 357-60. PMID 5932087  0.638
1966 Berenblum I, Boiato L, Trainin N. On the mechanism of urethan leukemogenesis in newborn C57BL mice. II. Influence of thymectomy and of subsequent thymus reimplantation. Cancer Research. 26: 361-3. PMID 5930684  0.604
1966 Berenblum I, Boiato-Chen L, Trainin N. Influence of thymectomy and subsequent thymus implantation on leukemia induction in adult C57BL mice by radiation and urethan. Cancer Research. 26: 1383-5. PMID 5916483 DOI: 10.1097/00007890-196701000-00019  0.625
1965 BERENBLUM I, CIVIDALLI G, TRAININ N, HODES ME. SOME PROPERTIES OF "RLP"--A FACTOR FROM SHEEP SPLEEN CAPABLE OF INHIBITING RADIATION LEUKEMOGENESIS IN MICE. Blood. 26: 8-19. PMID 14314404  0.619
1965 Berenblum I, Cividalli G, Trainin N, Hodes ME. Some Properties of RLP—A Factor from Sheep Spleen Capable of Inhibiting Radiation Leukemogenesis in Mice Blood. 26: 8-19. DOI: 10.1182/Blood.V26.1.8.8  0.388
1964 BERENBLUM I, CIVIDALLI G, HODES ME, TRAININ N. A FACTOR ('RLP') FROM SHEEP SPLEEN WHICH INHIBITS RADIATION LEUKAEMOGENESIS IN MICE. Nature. 202: 973-4. PMID 14197329 DOI: 10.1038/202973A0  0.652
1964 BERENBLUM I, BOIATO L, FIOREDONATI L, TRAININ N. ACTION OF ISOLOGOUS BONE MARROW FROM URETHAN-TREATED C57BL-6 MICE ON RADIATION LEUKEMOGENESIS. Journal of the National Cancer Institute. 32: 723-9. PMID 14133647 DOI: 10.1093/Jnci/32.3.723  0.651
1964 TRAININ N, KAYE AM, BERENBLUM I. INFLUENCE OF MUTAGENS ON THE INITIATION OF SKIN CARCINOGENESIS. Biochemical Pharmacology. 13: 263-7. PMID 14129406 DOI: 10.1016/0006-2952(64)90144-3  0.614
1963 BERENBLUM I, TRAININ N. THE LACK OF EFFECT OF URETHAN (ETHYL CARBAMATE) ON SARCOMA INDUCTION BY THE SUBCUTANEOUS INJECTION OF 3,4-BENZPYRENE. Cancer Research. 23: 983-6. PMID 14050769  0.552
1963 Trainin N. Neoplastic Nature Of Liver "Blood Cysts" Induced By Urethan In Mice. Journal of the National Cancer Institute. 31: 1489-1499. DOI: 10.1093/Jnci/31.6.1489  0.349
1962 HARAN-GHERA N, TRAININ N, FIORE-DONATI L, BERENBLUM I. A possible two-stage mechanism in rhabdomyosarcoma induction in rats. British Journal of Cancer. 16: 653-64. PMID 13952704 DOI: 10.1038/Bjc.1962.76  0.575
1961 BERENBLUM I, TRAININ N. Leukemogenesis by urethan in C57B1 mice bearing isologous tissues from x-irradiated mice. Science (New York, N.Y.). 134: 2045-7. PMID 13867499 DOI: 10.1126/science.134.3495.2045  0.631
1961 BERENBLUM I, REWALD FE, TRAININ N. Failure of bone marrow to interfere with the augmentation of x-ray leukemogenesis by urethan. Journal of the National Cancer Institute. 27: 1361-7. PMID 13867498 DOI: 10.1093/Jnci/27.6.1361  0.61
1960 BERENBLUM I, TRAININ N. Possible two-stage mechanism in experimental leukemogenesis. Science (New York, N.Y.). 132: 40-1. PMID 13799157 DOI: 10.1126/science.132.3418.40  0.58
1960 BERENBLUM I, KAYE AM, TRAININ N. In vivo tests for a carcinogenic metabolite in plasma of animals given injections of ethyl carbamate (urethan). Cancer Research. 20: 38-43. PMID 13799156  0.525
1959 BERENBLUM I, BLUM B, TRAININ N. Failure of the urethane antagonist-lysergic acid-diethylamide (LSD-25)--to inhibit lung carcinogenesis or the initiating phase of skin carcinogenesis in mice. Biochemical Pharmacology. 2: 197-9. PMID 13799155 DOI: 10.1016/0006-2952(59)90068-1  0.615
1959 BERENBLUM I, BEN-ISHAI D, HARAN-GHERA N, LAPIDOT A, SIMON E, TRAININ N. Skin initiating action and lung carcinogenesis byderivatives of urethane (ethyl carbamate) and related compounds. Biochemical Pharmacology. 2: 168-76. PMID 13799154 DOI: 10.1016/0006-2952(59)90065-6  0.581
1958 BERENBLUM I, HARAN-GHERA N, TRAININ N. An experimental analysis of the hair cycle effect in mouse skin carcinogenesis. British Journal of Cancer. 12: 402-13. PMID 13596493 DOI: 10.1038/Bjc.1958.48  0.571
Show low-probability matches.